A study highlights insufficient standardized safety and efficacy assessments for FDA-cleared AI/ML medical devices.
Key Details
- 1Cross-sectional analysis of FDA-cleared AI/ML-enabled devices was conducted.
- 2The study found lack of standardized efficacy and safety reporting in device clearance.
- 3Suggested need for dedicated regulatory pathways and post-market AI/ML safety surveillance.
- 4Study was published in JAMA Health Forum and led by Dr. Ravi B. Parikh.
Why It Matters
As imaging AI tools increasingly enter clinical use, robust regulatory oversight is critical for patient safety and clinician trust. Gaps in FDA reporting and surveillance could impact the safe integration of AI in radiology practice.
Source
EurekAlert
Related News
•EurekAlert
MIT Introduces Interactive AI System for Fast Medical Image Annotation
MIT researchers have developed MultiverSeg, an interactive AI tool enabling efficient, user-driven segmentation of biomedical image datasets without prior model training.
•EurekAlert
Imaging AI Tool Predicts MS Drug Response Using Cell Morphology
Brazilian and French researchers have developed an imaging-based AI tool to predict how multiple sclerosis patients will respond to natalizumab treatment.
•EurekAlert
MoBluRF Enables Sharp 4D Reconstructions from Blurry Video with NeRF
Researchers developed MoBluRF for creating sharp, dynamic 3D neural radiance fields from blurry monocular videos.